Share
Hutchinson Institute for Cancer Outcomes Research
Research Priorities
HICOR strives to reduce the human and economic burden of cancer by conducting innovative research in the following areas:
Financial impact of cancer
Cancer outcomes
Cost-effectiveness research
Pragmatic clinical trials
Economic assessment of technologies and treatments
Cancer policy
Value of information
Cancer care delivery research
HICOR co-director Dr. Gary Lyman explains how HICOR partners with care providers, insurance companies, patient advocates, drug companies and other researchers to untangle the financial burden cancer patients face through treatment.